Medical and Pharmaceutical Roche secures rights to Chinese biotech company’s small cell lung cancer drug Innovent Biologics will receive up to US$1 billion in milestone payments and royalties Rowan DunneJanuary 3, 2025
Medical and Pharmaceutical Russia develops mRNA cancer vaccine for citizens, skepticism lingers An absence of data has rendered the announcement questionable Rowan DunneJanuary 2, 2025
AI and Autonomy The Best of 2024: A Mugglehead roundup The year’s economic landscape as 2024 comes to a close demonstrates the resilience and adaptability of key sectors Joseph MortonDecember 30, 2024
Medical and Pharmaceutical RAPT Therapeutics sees 113% spike on allergy med licensing deal & private placement The biotech operator can develop and commercialize Jemincare's food allergy medication throughout most of the world Rowan DunneDecember 23, 2024
Medical and Pharmaceutical Krystal Biotech reports success with inhalable lung cancer drug in early-stage trial KB707 demonstrated a 27% objective response rate and 73% disease control rate Rowan DunneDecember 19, 2024
Medical and Pharmaceutical Scientists develop scan technique to light up aggressive lung cancer ‘like a Christmas tree’ More treatment innovation just in time for the holidays Rowan DunneDecember 18, 2024
Medical and Pharmaceutical Portage Biotech soars after initiating proceedings for iOx Therapeutics sale The stock went up by over 185% after the LOI was announced Rowan DunneDecember 17, 2024
Medical and Pharmaceutical Sagimet Biosciences up 30% on strong clinical stage data Denifanstat received FDA Breakthrough Therapy designation for metabolic dysfunction-associated steatohepatitis Joseph MortonDecember 16, 2024
Medical and Pharmaceutical Cizzle Biotechnology expands lung cancer blood biopsy test distribution into Caribbean This UK oncology company was spun out from the University of York's Department of Biology Rowan DunneDecember 16, 2024
Medical and Pharmaceutical Immutep starts multinational Phase III lung cancer drug trial at 150 sites It will examine the efficacy of 'eftilagimod alfa' in conjunction with Merck's Keytruda drug and chemo Rowan DunneDecember 12, 2024